Countermeasures and follow-up actions in response to information on thyroid cancer, which possibly provoked misunderstanding and unfounded rumour, issued by five former Japanese prime ministers
Open Access
- 13 November 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 200 (16-18) , 1519-1523
Abstract
This study summarises the responses to information on thyroid cancer, which possibly provoked misunderstanding and unfounded rumour, described in a letter issued by five former Japanese Prime Ministers on 27 January, 2022. Fukushima Medical University (FMU) implemented countermeasures and follow-up in three phases in response to the letter. In Phase 1, FMU shared scientific facts on the relationship between radiation exposure and thyroid cancer, as well as the response of FMU towards those who read the letter and were concerned about the description. Furthermore, FMU organised lectures and workshops to facilitate peer support among medical and non-medical staff, which were publicised through a newspaper article. In Phase 2, the peer support programme targeting patients with thyroid cancer was launched. In Phase 3, FMU participated in a TV programme to explain the medical aspects of thyroid cancer and the importance of providing peer support to patients with cancer, featuring individuals with experiences as medical staff and survivors.Keywords
This publication has 3 references indexed in Scilit:
- The “GU-GU-RU” project to eliminate discrimination related to the health effects of the Fukushima nuclear accidentBMC Public Health, 2023
- Political issues encouraging discrimination and prejudice associated with radiation exposure in the Fukushima Daiichi Nuclear Power Plant (FDNPP) incident for political purposes: a case of five former Japanese prime ministersJournal of Radiological Protection, 2022
- Combating ‘fake news’ and social stigma after the Fukushima Daiichi Nuclear Power Plant incident—the importance of accurate longitudinal clinical dataQJM: An International Journal of Medicine, 2019